PVI
DXCM icon

Pura Vida Investments’s DexCom DXCM Stock Holding History

Pura Vida Investments’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30,000
Closed -$4.16M – 52
2024
Q1 		$4.16M Buy
30,000
+3,843
+15% +$483K 0.7% 27
2023
Q4 		$3.25M Buy
26,157
+7,757
+42% +$792K 0.5% 29
2023
Q3 		$1.72M Buy
+18,400
New +$2.07M 0.32% 61
2023
Q1 		– Sell
-71,139
Closed -$8.06M – 106
2022
Q4 		$8.06M Buy
71,139
+14,439
+25% +$1.59M 0.42% 62
2022
Q3 		$4.57M Buy
+56,700
New +$4.8M 0.26% 91
2022
Q1 		– Sell
-105,248
Closed -$14.1M – 245
2021
Q4 		$14.1M Sell
105,248
-3,160
-3% -$454K 0.51% 52
2021
Q3 		$14.8M Buy
108,408
+3,132
+3% +$395K 0.45% 56
2021
Q2 		$11.2M Sell
105,276
-1,692
-2% -$162K 0.35% 65
2021
Q1 		$9.61M Buy
106,968
+4,236
+4% +$398K 0.27% 74
2020
Q4 		$9.5M Hold
102,732
– – 0.35% 72
2020
Q3 		$10.6M Buy
102,732
+4,800
+5% +$501K 0.55% 39
2020
Q2 		$9.93M Sell
97,932
-50,800
-34% -$4.54M 0.95% 25
2020
Q1 		$10M Sell
148,732
-71,596
-32% -$4.46M 1.19% 26
2019
Q4 		$12M Buy
220,328
+40,328
+22% +$1.91M 1.06% 33
2019
Q3 		$6.72M Sell
180,000
-69,148
-28% -$2.69M 1.15% 32
2019
Q2 		$9.33M Sell
249,148
-10,000
-4% -$314K 1.42% 20
2019
Q1 		$7.72M Sell
259,148
-30,852
-11% -$1.08M 1.1% 26
2018
Q4 		$8.69M Buy
290,000
+107,760
+59% +$3.42M 1.73% 12
2018
Q3 		$6.52M Buy
182,240
+82,240
+82% +$2.55M 1.37% 17
2018
Q2 		$2.38M Sell
100,000
-48,560
-33% -$1.03M 0.95% 37
2018
Q1 		$2.75M Buy
+148,560
New +$2.2M 1.63% 22
2017
Q4 		– Sell
-480,000
Closed -$6.24M – 79
2017
Q3 		$5.87M Buy
+480,000
New +$8.48M 1.72% 20
2017
Q2 		– Sell
-140,000
Closed -$2.97M – 76
2017
Q1 		$2.97M Buy
+140,000
New +$2.73M 0.88% 48

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pura Vida Investments's DXCM Position: Q2 2024 in Review

Pura Vida Investments sold out of DexCom (DXCM) in Q2 2024, closing a stake of 30,000 shares — an estimated $4.16M sold.

Pura Vida Investments first reported a position in DXCM in Q1 2017 and held it in 23 quarters. The position peaked at $14.8M in Q3 2021. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Pura Vida Investments reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Pura Vida Investments sold 30,000 DexCom shares in Q2 2024, an estimated $4.16M.
  • Pura Vida Investments first reported a position in DexCom in Q1 2017 and held it in 23 quarters.
  • Pura Vida Investments's DexCom position peaked at $14.8M in Q3 2021.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Pura Vida Investments's 13F filing for Q2 2024, filed 14 Aug 2024.